
An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D.
About this episode
Elitza Theel, Ph.D., explains how Mayo Clinic Laboratories' unique Histoplasma and Blastomyces test provides cost-effective evaluation for fungal infections that cause pulmonary illness. The assay reliably detects both Histoplasma and Blastomyces pathogens in a single test.
(00:32)
Will you please give us a brief introduction of yourself and your role at Mayo Clinic?
(01:34)
Can you tell us which specific group of patients this test would be best suited for, how a provider would determine a patient might benefit from this test, and when during the care process it should be ordered?
(04:56)
Can you explain how this new test is different, and why a provider might consider requesting it instead of the usual test?
(08:00)
When should the different tests be used?
(09:34)
Is this the only existing assay that can reliably detect antigen from both of these fungal pathogens?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab

Unique Assays Advance Care of Complex Autoimmune Skin Conditions
Answers from the Lab

Digital Advances: What’s Next for Clinical Diagnostics?
Answers from the Lab

Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes
Answers from the Lab

Breakthrough Test Enhances Peripheral Neuropathy Care and Research
Answers from the Lab